Icon

SEGLUROMET (nda209806)- (2.5MG;500MG,2.5MG;1GM,7.5MG;500MG,7.5MG;1GM)

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE MSD SUB MERCK
2.5MG;500MG,2.5MG;1GM,7.5MG;500MG,7.5MG;1GM
No Yes
2030-Oct-21 2022-Dec-19
None None
None No
SEGLUROMET is a combination of ertugliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 0 0
Total Other Developers 4
Drugs with Suitability No
2.5MG;500MG ** ** - - -
2.5MG;1GM ** ** Up - -
7.5MG;500MG ** ** Up - -
7.5MG;1GM ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.